Core Insights - Vivakor, Inc. has entered into a Collaboration Agreement with Neuralix, Inc. to integrate advanced AI technology into its midstream operations and establish a joint venture for co-marketing the AI platform to third-party operators in the midstream energy sector [1][2][4] Company Overview - Vivakor, Inc. is an integrated provider of sustainable energy transportation, storage, reuse, and remediation services, operating one of the largest fleets of oilfield trucking services in the continental United States [5] - The company's mission focuses on developing, acquiring, and operating assets and technologies in the energy sector, with services including crude oil and produced water gathering, storage, transportation, reuse, and remediation under long-term contracts [5] Collaboration Details - The collaboration with Neuralix aims to optimize Vivakor's core business functions, including transportation and route optimization, predictive maintenance, and resource allocation [2][7] - The initial deployment will focus on dynamic routing to reduce fuel costs and emissions, AI-driven monitoring of assets to minimize downtime, and real-time decision support for storage and remediation projects [7] Strategic Goals - This partnership is part of Vivakor's broader strategy to embrace digital transformation, enhance profitability, reduce environmental impact, and deliver reliable services to customers [4] - The companies expect to finalize the Joint Venture Agreement by the end of 2025, subject to ongoing negotiations [4]

Core Insights - SEALSQ Corp is making significant advancements in developing quantum-resistant hardware security modules, positioning itself as a leader in the post-quantum technology space [2][4][8] Industry Context - The U.S. Government has mandated compliance with quantum-resistant cryptography for National Security Systems by January 1, 2027, highlighting the urgency for organizations to adopt post-quantum cryptography [3] - The National Institute of Standards and Technology (NIST) has finalized the first post-quantum cryptography standards, which will form the foundation for secure infrastructures in the future [3] Company Positioning - SEALSQ is on track to deliver the first post-quantum cryptography-capable Trusted Platform Module (TPM) samples, integrating advanced algorithms directly into the chip's design for enhanced security and efficiency [4][5] - Unlike competitors, SEALSQ's QVault TPM will provide full post-quantum cryptography capabilities across all functions, ensuring faster and more secure cryptographic operations [5] Applications and Use Cases - Trusted Platform Modules are essential for modern security architectures, supporting secure boot processes, cryptographic key storage, and device authentication, with applications in various critical industries [6] - The introduction of quantum-resistant TPMs will extend the use cases of TPMs, safeguarding sensitive infrastructures and digital identities against future quantum threats [6] Leadership Perspective - The CEO of SEALSQ emphasized the importance of providing trusted hardware that meets current and future security standards, indicating a proactive approach to the challenges posed by quantum computing [7]

FREDERICK, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced that Dr. Halden Shane, Chief Executive Officer, and David Vanston, Chief Financial Officer, will be participating in the H.C. Wainwright 25th Annual Global Investment Conference to be held September 8-10, 2025 a ...

THE WOODLANDS, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Company will present new data demonstrating the reduction of neuropathic pain by pilavapadin in preclinical models of chemotherapy-induced peripheral neuropathy (CIPN) and multiple sclerosis (MS) at the 9th International Congress on Neuropathic Pain - (NeuPSIG) 2025. The findings highlight the relevance of inhibiting pilavapadin’s novel target, AAK1, for the modulation of pain signa ...

Core Insights - Fuel Tech, Inc. is scheduled to present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, in New York City [1] - The presentation will take place on September 9, 2025, at 1:00 pm Eastern Time, with a live webcast available on the company's website [2] Company Overview - Fuel Tech specializes in advanced engineering processes for emissions control systems and water treatment technologies, serving utility and industrial applications [1][3] - The company is a leader in nitrogen oxide (NOx) reduction and particulate control technologies, with over 1,300 installations worldwide [3] - Fuel Tech's FUEL CHEM technology enhances the efficiency and environmental performance of combustion units by addressing issues like slagging and fouling [3] - The company's water treatment technologies include DGIDissolved Gas Infusion Systems, which utilize patented methods for delivering supersaturated oxygen solutions for various applications in water and wastewater industries [3] - Fuel Tech's products leverage advanced Computational Fluid Dynamics modeling and high-end visualization software to optimize performance [3]

PROVIDENCE, Rhode Island , Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Beeline Holdings, Inc. (Nasdaq: BLNE) (“Beeline” or the “Company”), the fast-growing digital mortgage platform redefining the path to homeownership, today announced that it has successfully paid down all of its outstanding debt. This excludes the Company’s warehouse lines, which are used exclusively to fund mortgage transactions that generate revenue for Beeline. These loans are typically held for approximately 20 business days before b ...

Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistanceAdditional poster presentations highlight SCY-247’s broad spectrum of antifungal activity, against Candida species, including multidrug- and pandrug-resistant C. auris and Aspergillus speciesCompany anticipates reporting Phase 1 Single Ascending Dose/Multiple Ascending Dose (SAD/MAD) data for SCY-247 (oral) in Q3 2025 JERSEY C ...

Core Insights - Profusa, Inc. is expanding its customer base in Europe through a collaboration with AZ Sint Blasius Hospital in Belgium, led by Dr. Koen Deloose, a recognized expert in critical limb ischemia [1][3] - Dr. Deloose's clinic employs a multidisciplinary approach to treat patients, integrating specialists in diabetic foot care, wound care, and podiatry [2] - Profusa's Lumee Oxygen monitoring system is expected to enhance treatment outcomes for patients with critical limb ischemia by providing real-time tissue oxygen metrics [2][3] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemical data [4] - The company aims to provide affordable, long-lasting biosensors that deliver actionable medical-grade data for both personal and clinical use [4] Leadership and Research - Dr. Koen Deloose has a significant background in vascular medicine, having authored over 200 articles in peer-reviewed journals and holding leadership roles in various medical organizations [2] - Profusa's CEO, Ben Hwang, emphasizes the alignment of Dr. Deloose's clinical work with the company's mission to improve health through accessible biochemical monitoring [3]

Core Points - CytoDyn Inc. is a clinical-stage biotechnology company focused on advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications [1][2] - The company announced a change in the timing of its management's live presentation at the H.C. Wainwright 27th Annual Global Investment Conference to September 10, 2025, at 9 a.m. EDT [1][2] - CytoDyn's mission is to improve patients' quality of life through therapeutic innovation, emphasizing integrity, responsibility, and service [3] Event Details - The H.C. Wainwright 27th Annual Global Investment Conference will take place from September 8-10, 2025, in New York City [2] - CFO Robert E. Hoffman will deliver a live presentation and be available for one-on-one meetings during the event [2] Company Information - CytoDyn is dedicated to bringing transformative treatments to patients worldwide, particularly focusing on immune function related to cancer, infectious diseases, and autoimmune disorders [2][3] - For more information, the company can be contacted through its investor relations email or its media contacts [4]

Core Viewpoint - Inuvo, Inc. will participate in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, showcasing its AI AdTech solutions [1]. Company Participation - Management is scheduled to present on September 8, 2025, at 11:30 AM Eastern Time, with a live webcast available [2]. - Management will engage in one-on-one meetings with qualified investors throughout the conference [3]. Company Overview - Inuvo, Inc. is a leader in Artificial Intelligence for advertising, with its proprietary IntentKey AI solution that identifies consumer interests rather than demographics [4].